ACM
PMVP icon

Asymmetry Capital Management’s PMV Pharmaceuticals PMVP Stock Holding History

Asymmetry Capital Management’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$2.26M Sell
97,680
-3,202
-3% -$77.4K 1.2% 22
2021
Q3 		$3.01M Sell
100,882
-894
-0.9% -$28.5K 1.81% 22
2021
Q2 		$3.48M Sell
101,776
-16,352
-14% -$546K 2.39% 16
2021
Q1 		$3.88M Buy
118,128
+21,533
+22% +$849K 2.01% 21
2020
Q4 		$5.94M Buy
96,595
+71,703
+288% +$2.81M 2.71% 15
2020
Q3 		$884K Buy
+24,892
New +$916K 0.57% 32

Other funds holding PMVP

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
Euclidean Capital New York $440M AUM 28.33% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Asymmetry Capital Management's PMVP Position: Q4 2021 in Review

Asymmetry Capital Management reduced its PMV Pharmaceuticals (PMVP) stake by 3.2% in Q4 2021, selling an estimated $77.4K and leaving 97,680 shares worth $2.26M. The position accounts for 1.2% of the portfolio, ranked #22.

Asymmetry Capital Management first reported a position in PMVP in Q3 2020 and has held it in 6 quarters since. The position peaked at $5.94M in Q4 2020. 105 funds tracked by Wall St. Rank hold PMVP as of Q4 2021.

  • Asymmetry Capital Management held 97,680 shares of PMV Pharmaceuticals worth $2.26M as of Q4 2021.
  • Asymmetry Capital Management sold 3,202 PMV Pharmaceuticals shares in Q4 2021, an estimated $77.4K.
  • PMV Pharmaceuticals made up 1.2% of Asymmetry Capital Management's portfolio in Q4 2021, its #22 holding.
  • Asymmetry Capital Management first reported a position in PMV Pharmaceuticals in Q3 2020 and has held it in 6 quarters since.
  • Asymmetry Capital Management's PMV Pharmaceuticals position peaked at $5.94M in Q4 2020.
  • 105 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q4 2021.

Based on Asymmetry Capital Management's 13F filing for Q4 2021, filed 19 Jan 2022.